http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2646353-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 |
| filingDate | 1989-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61fadf3d75145b8df9f02e8fc261a78b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5f94b7415f5c81b48c8e8f73afa63b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4af63f4309d5ef0aad288c76f7d64fcf |
| publicationDate | 1990-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2646353-A1 |
| titleOfInvention | USE OF PEPTIDES CONTAINING STATIN FOR THE PREPARATION OF MEDICINAL PRODUCTS USEFUL FOR THE TREATMENT OF VIRAL DISEASES |
| abstract | Use for the preparation of a medicament, intended for the treatment of viral diseases, of a compound of formula: RXY-Statyl1 -Ala-Statyl2 -R 'in which Statyl1 denotes the radical derived from the amino acid statin, namely : (CF DRAWING IN BOPI) and by Statyl2 the radical derived from the same amino acid, whether it is the 3S, 4S isomer or the 3R, 4S isomer; - R denotes a hydrogen atom or an acylating group attached to the terminal amino group of the amino acid X; - X and Y, which are identical or different, denote amino acid residues of L or D configuration when there is a center of asymmetry in the molecule, and optionally protected in their side chain, said amino acids being chosen from the following amino acids : - X: Phenylalanine, Tryptophan, Histidine, Boc-Histidine, Tyrosine, Proline, Isoleucine; - Y: Phenylalanine, Tryptophan, Histidine, Tyrosine, Proline, Leucine, Isoleucine, Valine, Glycine; - R 'represents OH, O-C1 -C6 alkyl or one of its pharmaceutically acceptable salts. Application: treatment of AIDS. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5554728-A |
| priorityDate | 1989-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.